Certara Products - BaseCase Archives | 第 3 页，共 4 页

Case Study

Using customer engagement technology to create value communication tools for ABILIFY MAINTENA® (aripiprazole)

Otsuka identified several weaknesses in their existing workflow for developing value communication tools. In particular,…

Certara2023 年 10 月 2 日

Conference

ISPOR Europe 2025

–

Certara2023 年 5 月 24 日

Conference

ACoP 2026

Certara2023 年 5 月 24 日

On-Demand Webinar

How digital communication tools will revolutionize your medical conversation

Medical Affair, Market Access, and Sales & Marketing teams at most of pharmaceutical companies use…

Certara2023 年 4 月 24 日

Conference

ISPOR International Annual Conference 2026

–

Certara2023 年 2 月 15 日

Blog

价值沟通制胜之道：导言

Drawn from the experiences of the BaseCase Consulting Team, this is the introduction to ‘Succeeding…

Certara2021 年 8 月 5 日

视频

What is BaseCase?

Developing interactive and easy-to-use stakeholder engagement content market access, medical affairs, and sales field teams…

Certara2021 年 7 月 20 日

Blog

Preparing for High Stakes Meetings; How to Best Convey a New Drug’s Value to Payers

This blog post includes key takeaways from the opening session of Certara’s first Strategic Evidence…

Certara2021 年 6 月 18 日

On-Demand Webinar

战略证据与价值传播研讨会

Join us on 2021 年 4 月 21 日, 星期三, from12:00 PM – 2:00 PM EDT for Certara’s…

Certara2021 年 3 月 26 日

White Paper

COVID-19 对利益相关者参与和价值传播的影响：准备迎接 New Normal

Certara2020 年 10 月 28 日

Certara Products – BaseCase

Using customer engagement technology to create value communication tools for ABILIFY MAINTENA® (aripiprazole)

ISPOR Europe 2025

ACoP 2026

How digital communication tools will revolutionize your medical conversation

ISPOR International Annual Conference 2026

价值沟通制胜之道：导言

What is BaseCase?

Preparing for High Stakes Meetings; How to Best Convey a New Drug’s Value to Payers

战略证据与价值传播研讨会

COVID-19 对利益相关者参与和价值传播的影响：准备迎接 New Normal

订阅时事通讯

快捷链接

解决方案

联系我们